Imaging the Substantia Nigra in Parkinson Disease and Other Parkinsonian Syndromes

Imaging the Substantia Nigra in Parkinson Disease and Other Parkinsonian Syndromes
Radiology. 2021 Jun 8:203341. doi: 10.1148/radiol.2021203341. Online ahead of print.ABSTRACTParkinson disease is characterized by dopaminergic cell loss in the substantia nigra of the midbrain. There are various imaging markers for Parkinson disease. Recent advances in MRI have enabled elucidation of the underlying pathophysiologic changes in the nigral structure. This has contributed to accurate and early diagnosis and has improved disease ... read more
Source: PubMedPublished on 2021-06-08By Yun Jung Bae